Wei Lei
5 Papers
6 Citations
Wei Lei is an academic researcher. The author has contributed to research in topics: Hypoxia-inducible factors & Kinase. The author has an hindex of 3, co-authored 5 publications.
Chat about Author
Papers
Determination of Abscisic Acid and its Relationship to Drought Stress Based on Cowpea Varieties with Different Capability of Drought Resistance
TL;DR: The endogenous ABA decreased under drought treatment and the drought sensitive line had higher ABA content than drought resistant one, suggesting ABA performs a vital function in cowpea’s response and resistance to drought stress.
•Journal Article
Roles of microRNA in vascular diseases in cardiac and pulmonary systems.
TL;DR: The current knowledge on the roles of miRNAs in the development of vascular diseases, especially in CAD and PAH is summarized, providing a theoretical basis for potential uses of miRNA in diagnosis, prognosis, and therapy in these cardiovascular diseases.
4
In silico Analysis of 4CL Family in Scutellaria baicalensis through Biocomputational Tools and Servers
TL;DR: In silico analysis of Sv4CL was finished, which would pave for further studies of physichemical properties of 4CL family and its related molecular mechanism of flavonoid metabolic regulation.
2
Expression and analyses of the HIF-1 pathway in the lungs of humans with pulmonary arterial hypertension
Wei Lei,Yuan He,Xiaorong Shui,Guoming Li,Guosen Yan,Yu Zhang,Shian Huang,Can Chen,Yuanlin Ding +8 more
TL;DR: The expression and phosphorylation levels of HIF and its associated pathways, including extracellular signal‑regulated kinase (Erk)1/2 and phosphoinositide 3‑kinase (PI3K)/Akt, are determined in the lungs of patients with PAH by reverse transcription‑quantitative polymerase chain reaction and western blotting and suggested that the mitogen‑activated protein kinase and PI3K/Akt signaling pathways, and HIF‑1 may
Aryl hydrocarbon receptor pathway: Role, regulation and intervention in atherosclerosis therapy (Review).
TL;DR: The current review presents the molecular mechanisms involved in the regulation of AhR expression during inflammation, oxidative stress and lipid deposition and the role of the AhR in atherosclerosis and Atherosclerosis-associated diseases is reviewed.